Literature DB >> 15751279

The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases.

Makoto Kimura1, Kenji Tani, Junya Miyata, Keiko Sato, Akihito Hayashi, Shinsaku Otsuka, Tomoyuki Urata, Saburo Sone.   

Abstract

To determine the significance of proteases in interstitial lung diseases, we examined the activity of cathepsins, thrombin, and aminopeptidase in bronchoalveolar lavage (BAL) fluid from patients with these disorders. Significantly increased activities of cathepsin H and aminopeptidase were detected in BAL fluid from patients with idiopathic pulmonary fibrosis (IPF), cryptogenic organizing pneumonia (COP), chronic eosinophilic pneumonia (CEP) and hypersensitivity pneumonitis (HP). Significantly higher activity of cathepsin B was found in BAL fluid from patients with CEP. The activity of thrombin was significantly higher in patients with IPF and CEP. In patients with IPF, there were significant correlations between neutrophil number and the activity of cathepsin B, cathepsin H or aminopeptidase. In patients with COP and HP, the activity of the proteases was significantly higher in patients with higher number of lymphocytes than in those with lower number of lymphocytes. The present study suggests that the activity of the proteases is a useful marker in activity of the interstitial lung diseases, and may have a role in the pathogenesis of these disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15751279     DOI: 10.2152/jmi.52.93

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  6 in total

1.  Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages.

Authors:  Kamran Atabai; Sina Jame; Nabil Azhar; Alex Kuo; Michael Lam; William McKleroy; Greg Dehart; Salman Rahman; Dee Dee Xia; Andrew C Melton; Paul Wolters; Claire L Emson; Scott M Turner; Zena Werb; Dean Sheppard
Journal:  J Clin Invest       Date:  2009-11-02       Impact factor: 14.808

2.  Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice.

Authors:  Elizabeth M Pierce; Kristin Carpenter; Claudia Jakubzick; Steven L Kunkel; Kevin R Flaherty; Fernando J Martinez; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

3.  Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells.

Authors:  Seijitsu Ando; Hitomi Otani; Yasuhiro Yagi; Kenzo Kawai; Hiromasa Araki; Shirou Fukuhara; Chiyoko Inagaki
Journal:  Respir Res       Date:  2007-04-16

4.  Development of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease.

Authors:  Daniel Guldager Kring Rasmussen; Jannie Marie Bülow Sand; Morten Asser Karsdal; Federica Genovese
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

5.  Safety and efficacy of bleomycin/pingyangmycin-containing chemotherapy regimens for malignant germ cell tumor patients in the female genital system.

Authors:  Qianying Zhao; Dongyan Cao; Mei Yu; Jiaxin Yang; Yongjian Liu; Yang Xiang; Ming Wu; Lingya Pan; Jinghe Lang; Kaifeng Xu; Jiangna Han; Keng Shen
Journal:  Oncotarget       Date:  2017-02-28

6.  Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.

Authors:  Yan Xie; Haihong Jiang; Qian Zhang; Suneet Mehrotra; Peter W Abel; Myron L Toews; Dennis W Wolff; Stephen Rennard; Reynold A Panettieri; Thomas B Casale; Yaping Tu
Journal:  Respir Res       Date:  2016-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.